Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Drug-resistant TB

New TB drug: When 400 just won’t do...

12 Apr 2017
 
Drug-resistant TB

School-going TB patients speak out about a crisis in adolescent TB healthcare 

Press Release 24 Mar 2017
 
Drug-resistant TB

Xoliswa Harmans: "Turning support for TB patients into a community tradition"

Fieldworkers Stories 24 Mar 2017
 
Videos and Photos

Action speaks louder than words - Phumlani story

24 Mar 2017
Videos and Photos
 
Drug-resistant TB

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval

Press Release 23 Mar 2017
 
Drug-resistant TB

Open letter regarding registration and availability of delamanid in South Africa

Speech 22 Mar 2017